An emerging way to treat cancer is immunotherapy, where the patient’s immune system is strengthened to attack cancer cells. It is less painful than surgery, chemotherapy or radiation therapy, and is known to lower the relapse of cancer. Now, researchers at the Indian Institute of Technology Bombay (IIT Bombay) have developed a patented technology to leverage the patient’s immune system to cure cancer.

Human Mesenchymal Stem Cells found to favour the survival of tuberculosis bacteria, instead of fighting it, shows a recent study.

“As the world confronts the COVID-19 pandemic, humanity’s victory over smallpox is a reminder of what is possible when nations come together to fight a common health threat,” said Tedros Adhanom, Director-General of the World Health Organisation (WHO), in a recent media briefing.